Smarter scans may allow safer radiation for recurring prostate cancer

NCT ID NCT07234981

Recruiting now Disease control Sponsor: University of Nebraska Source: ClinicalTrials.gov ↗

First seen Nov 19, 2025 · Last updated May 24, 2026 · Updated 26 times

Summary

This study tests whether using a special PET scan (PSMA-PET) to guide radiation can reduce side effects while still controlling prostate cancer that has returned after surgery. About 54 men will receive a lower dose of radiation to the pelvis plus a higher dose to the exact spots seen on the scan, along with standard hormone therapy. The goal is to see if this approach causes fewer severe short-term side effects compared to historical rates, while keeping the cancer in check for at least two years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University of Nebraska Medical Center
RECRUITING

Omaha, Nebraska, 68198, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PROSTATE CANCER